SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome

Affiliations

• ¹ Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
• ² Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
• ³ Dutch Childhood Oncology Group, Utrecht, The Netherlands.
• ⁴ Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
• ⁵ Oncode Institute, Utrecht, The Netherlands.
• ⁶ Department of Human Genetics, Medical School Hannover, Hannover, Germany.
• ⁷ Department of Haematology, Great Ormond Street Hospital, London, United Kingdom.
• ⁸ Royal Belfast Hospital for Sick Children, Belfast, United Kingdom.
• ⁹ University College London's NHS Foundation Trust, London, United Kingdom.
• ¹⁰ Cytogenetics, Viapath Haemato-Oncology Diagnostics Centre, King's College Hospital, London, United Kingdom.
• ¹¹ Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
• ¹² German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany.
• ¹³ Centro Ricerca Tettamanti, Department of Medicine, Università di Milano-Bicocca, Monza, Italy; and.
• ¹⁴ Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.